Researcher Profile

Researcher Profile

Kentaro Minagawa, MD, PhD

Kentaro Minagawa, MD, PhD

Assistant Professor, Department of Medicine
Division of Hematology and Oncology
Scientific Program:Next-Generation Therapies

Research Interests

  • Therapeutics
  • T-Lymphocytes
  • Genes
  • Neoplasms
  • Bone Marrow
  • Mycophenolic Acid
  • Hematopoietic Stem Cell Transplantation
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Hematopoietic Stem Cells
  • Follicular Lymphoma
  • Japan

Recent Publications


Ishii, S, Suzuki, T, Wakahashi, K, Asada, N, Kawano, Y, Kawano, H, Sada, A, Minagawa, K, Nakamura, Y, Mizuno, S, Takahashi, S, Matsui, T & Katayama, Y 2021, 'FGF-23 from erythroblasts promotes hematopoietic progenitor mobilization', Blood, vol. 137, no. 11, pp. 1457-1467.


Minagawa, K, Al-Obaidi, M & Di Stasi, A 2019, Generation of suicide gene-modified chimeric antigen receptor-redirected T-cells for cancer immunotherapy. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1895, Humana Press Inc., pp. 57-73.
Wakahashi, K, Minagawa, K, Kawano, Y, Kawano, H, Suzuki, T, Ishii, S, Sada, A, Asada, N, Sato, M, Kato, S, Shide, K, Shimoda, K, Matsui, T & Katayama, Y 2019, 'Vitamin D receptor–mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis', Blood, vol. 133, no. 15, pp. 1619-1629.


Wakahashi, S, Kawakami, F, Wakahashi, K, Minagawa, K, Matsuo, K, Katayama, Y, Yamada, H, Matsui, T & Sudo, T 2018, 'Transformed Follicular Lymphoma (TFL) predicts outcome in advanced endometrial cancer', Cancer Epidemiology Biomarkers and Prevention, vol. 27, no. 8, pp. 963-969.


Kawano, Y, Fukui, C, Shinohara, M, Wakahashi, K, Ishii, S, Suzuki, T, Sato, M, Asada, N, Kawano, H, Minagawa, K, Sada, A, Furuyashiki, T, Uematsu, S, Akira, S, Uede, T, Narumiya, S, Matsui, T & Katayama, Y 2017, 'G-CSF-induced sympathetic tone provokes fever and primes antimobilizing functions of neutrophils via PGE2', Blood, vol. 129, no. 5, pp. 587-597.
Minagawa, K, Falcon, CP & Matsui, T 2017, 'Very-Low-Dose Lenalidomide for Elderly and/or Frail Multiple Myeloma Patients: Lower Might Be Better', Acta Haematologica, vol. 138, no. 1, pp. 52-54.

Clinical Trials Search

Children (age < 18 years)
Adults (age >= 18 years)